Published in Environ Health Perspect on December 01, 2007
Radiation exposure from CT in early childhood: a French large-scale multicentre study. Br J Radiol (2012) 1.09
A systematic review and meta-analysis of childhood leukemia and parental occupational pesticide exposure. Environ Health Perspect (2009) 1.05
Road traffic and childhood leukemia: the ESCALE study (SFCE). Environ Health Perspect (2010) 1.03
Residential pesticides and childhood leukemia: a systematic review and meta-analysis. Environ Health Perspect (2010) 1.01
Residential exposures to pesticides and childhood leukaemia. Radiat Prot Dosimetry (2008) 0.95
Home pesticide exposures and risk of childhood leukemia: Findings from the childhood leukemia international consortium. Int J Cancer (2015) 0.91
Estimating retrospective exposure of household humidifier disinfectants. Indoor Air (2015) 0.89
In utero pesticide exposure and leukemia in Brazilian children < 2 years of age. Environ Health Perspect (2012) 0.89
Parental occupational pesticide exposure and the risk of childhood leukemia in the offspring: findings from the childhood leukemia international consortium. Int J Cancer (2014) 0.88
Reliability of maternal-reports regarding the use of household pesticides: experience from a case-control study of childhood leukemia. Cancer Epidemiol (2012) 0.85
Spatial clustering and space-time clusters of leukemia among children in Germany, 1987-2007. Eur J Epidemiol (2010) 0.79
Pesticide-related illness reported to and diagnosed in primary care: implications for surveillance of environmental causes of ill-health. BMC Public Health (2009) 0.77
Pediatric acute lymphoblastic leukemia and exposure to pesticides. Ther Drug Monit (2009) 0.77
Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: a French case-control study. Int J Cancer (2009) 0.76
Knowing the enemy: ant behavior and control in a pediatric hospital of Buenos Aires. Springerplus (2014) 0.75
Residential Exposure to Natural Background Radiation and Risk of Childhood Acute Leukemia in France, 1990-2009. Environ Health Perspect (2016) 0.75
A task-based assessment of parental occupational exposure to pesticides and childhood acute lymphoblastic leukemia. Environ Res (2017) 0.75
ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study. PLoS One (2015) 0.75
Passive exposure to agricultural pesticides and risk of childhood leukemia in an Italian community. Int J Hyg Environ Health (2016) 0.75
Childhood leukemia and parents' occupational and home exposures. J Natl Cancer Inst (1987) 3.03
Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology (1999) 2.85
Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group. Cancer Res (1989) 2.55
Pesticides and childhood cancers. Environ Health Perspect (1997) 2.51
Pesticides and childhood cancer. Environ Health Perspect (1998) 2.29
Home pesticide use and childhood cancer: a case-control study. Am J Public Health (1995) 1.85
Pesticide storage and use patterns in Minnesota households with children. J Expo Anal Environ Epidemiol (2000) 1.74
Leukemia and non-Hodgkin's lymphoma in childhood and exposure to pesticides: results of a register-based case-control study in Germany. Am J Epidemiol (2000) 1.53
Pesticides and childhood cancer: an update of Zahm and Ward's 1998 review. J Toxicol Environ Health B Crit Rev (2007) 1.52
Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect (2002) 1.52
Childhood leukaemia and exposure to pesticides: results of a case-control study in northern Germany. Eur J Cancer (1996) 1.50
[Trends in perinatal health in metropolitan France between 1995 and 2003: results from the National Perinatal Surveys]. J Gynecol Obstet Biol Reprod (Paris) (2006) 1.43
Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999. Eur J Cancer Prev (2004) 1.43
Characterizing exposures to nonpersistent pesticides during pregnancy and early childhood in the National Children's Study: a review of monitoring and measurement methodologies. Environ Health Perspect (2005) 1.40
[Development of the main indicators of perinatal health in metropolitan France between 1995 and 1998. Results of the national perinatal survey]. J Gynecol Obstet Biol Reprod (Paris) (2001) 1.30
What's hiding under the sink: dangers of household pesticides. Environ Health Perspect (1995) 1.16
Cancer incidence among children in France, 1990-1999. Pediatr Blood Cancer (2004) 1.12
Household exposure to pesticides and risk of childhood acute leukaemia. Occup Environ Med (2006) 1.06
[The perinatal situation in France. Trends between 1981 and 1995]. J Gynecol Obstet Biol Reprod (Paris) (1997) 1.03
Pesticide exposures in children with non-Hodgkin lymphoma. Cancer (2000) 0.97
Exposure to pesticides and childhood cancer risk: has there been any progress in epidemiological studies? Int J Occup Med Environ Health (2006) 0.96
Pesticides and childhood cancer: an update. Int J Hyg Environ Health (2007) 0.95
Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE). Int J Cancer (2007) 0.94
Use and storage of domestic pesticides in the UK. Sci Total Environ (2006) 0.87
Parental marijuana use and risk of childhood acute myeloid leukaemia: a report from the Children's Cancer Group (United States and Canada). Paediatr Perinat Epidemiol (2006) 0.86
Do pesticides cause childhood cancer? Int Arch Occup Environ Health (2006) 0.85
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Excess mortality related to the August 2003 heat wave in France. Int Arch Occup Environ Health (2006) 3.56
Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol (2010) 3.27
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood (2005) 3.09
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol (2004) 2.81
Childhood leukemia around French nuclear power plants--the Geocap study, 2002-2007. Int J Cancer (2012) 2.76
Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica (2005) 2.66
Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med (2012) 2.60
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet (2002) 2.46
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood (2012) 2.39
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood (2007) 2.36
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. Lancet Oncol (2012) 2.29
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol (2003) 2.15
Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major. Haematologica (2006) 2.14
The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. Haematologica (2006) 2.09
Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci U S A (2006) 2.08
Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years. Br J Haematol (2014) 2.07
Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J Exp Med (2011) 2.04
CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease. Ann Neurol (2004) 2.03
Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer (2008) 2.02
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. Eur J Cancer (2007) 2.01
Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions. Blood (2011) 1.99
Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group. J Clin Oncol (2013) 1.97
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Ecological association between a deprivation index and mortality in France over the period 1997 - 2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Public Health (2009) 1.80
Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial. J Clin Oncol (2011) 1.80
Experimental designs for small randomised clinical trials: an algorithm for choice. Orphanet J Rare Dis (2013) 1.77
Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood (2011) 1.71
NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity. Blood (2008) 1.69
The impact of major heat waves on all-cause and cause-specific mortality in France from 1971 to 2003. Int Arch Occup Environ Health (2007) 1.66
SPRED1 disorder and predisposition to leukemia in children. Blood (2009) 1.65
High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder. Blood (2009) 1.65
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol (2010) 1.62
Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica (2012) 1.59
Treatment of B-cell lymphoma with LMB modified protocols in Africa--report of the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer (2008) 1.59
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Br J Haematol (2008) 1.59
Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results. Blood (2013) 1.59
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy. Blood (2012) 1.57
Professional exposure to pesticides and Parkinson disease. Ann Neurol (2009) 1.56
Activating mutations in human acute megakaryoblastic leukemia. Blood (2008) 1.56
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56
Thymus and mediastinal node involvement in childhood Langerhans cell histiocytosis: long-term follow-up from the French national cohort. Pediatr Blood Cancer (2013) 1.54
Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experience. Br J Haematol (2013) 1.49
Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J Clin Endocrinol Metab (2004) 1.46
Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia. Br J Haematol (2008) 1.46
Risk factors for Gram-negative bacterial infections in febrile neutropenia. Haematologica (2005) 1.44
Lymph node biopsy specimens and diagnosis of cat-scratch disease. Emerg Infect Dis (2006) 1.44
Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study. Lancet Oncol (2012) 1.41
Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia. Pediatrics (2005) 1.39
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet (2013) 1.39
Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric population. Ther Drug Monit (2014) 1.38
A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood (2011) 1.36
New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica (2011) 1.34
Rituximab therapy for childhood Evans syndrome. Haematologica (2007) 1.33
Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study. J Clin Oncol (2008) 1.32
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore) (2012) 1.31
Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol (2008) 1.29
Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia. Haematologica (2012) 1.28